SEARCH

SEARCH BY CITATION

References

  • 1
    Arai Y, Egawa S, Tobisu K et al. Radical retropubic prostatectomy: Time trends, morbidity and mortality in Japan. BJU. Int. 2000; 85: 28794.
  • 2
    Mettlin CJ, Murphy GP, Babaian RJ et al. Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection Project. Cancer 1997; 80: 181417.
  • 3
    Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: Differences based on treatment modality. J. Urol. 2001; 166: 94752.
  • 4
    Johnson TK, Gilliland FD, Hoffman RM et al. Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J. Clin. Oncol. 2004; 22: 4193201.
  • 5
    Penson DF, McLerran D, Feng Z, Li L et al. Five-year urinary and sexual outcomes after radical prostatectomy: Results from the prostate cancer outcomes study. J. Urol. 2005; 173: 17015.
  • 6
    Namiki S, Saito S, Satoh M et al. Quality of life after radical prostatectomy in Japanese men: Two-year longitudinal study. Jpn. J. Clin. Oncol. 2005; 35: 5518.
  • 7
    Walsh PC. Anatomical radical retropubic prostatectomy. In: WalshPC, RetikAB, VaughanED, WeinAJ (eds). Campbell's Urology, 8th edn. WB Saunders, Philadelphia, 2002; 310729.
  • 8
    Tsuzuki T, Hernandez DJ, Aydin H, Trock B, Walsh PC, Epstein JI. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate-specific antigen and digital rectal examination. J. Urol. 2005; 173: 4503.
  • 9
    Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993; 2: 21727.
  • 10
    Ware JE Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med. Care 1992; 30: 47383.
  • 11
    Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med. Care 1998; 36: 100212.
  • 12
    Barry MJ, Fowler FJ, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol. 1992; 148: 154977.
  • 13
    Fukuhara S, Ware Je, Koshinski M. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J. Clin. Epidemiol. 1998; 51: 104553.
  • 14
    Kakehi Y, Kamoto T, Osamu O, Arai Y, Litwin MS, Fukuhara S. Development Japanese version of the UCLA Prostate Cancer Index: A pilot validation study. Int. J. Clin. Oncol. 2002; 7: 30611.
  • 15
    Litwin MS, Melmed GY, Nakazon T. Life after radical prostatectomy: A longitudinal study. J. Urol. 2001; 166: 58792.
  • 16
    Talcott JA, Rieker P, Clark JA et al. Patient-reported symptoms after primary therapy for early prostate cancer; Results of a prospective cohort study. J. Clin. Oncol. 1998; 16: 27583.
  • 17
    Braslis KG, Santa-Cruz C, Brickman AL, Soloway MS. Quality of life 12 months after radical prostatectomy. Br. J. Urol. 1995; 154: 14205.
  • 18
    Talcott JA, Manola J, Clark JA et al. Time course and predictors of symptoms after primary prostate cancer therapy. J. Clin. Onco. 2003; 21: 397986.
  • 19
    Hoffman RH, Hunt WC, Stephenson RA. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Caner 2003; 97: 165362.
  • 20
    Namiki S, Terai A, Nakagawa H et al. Intraoperative electrophysiological confirmation of neurovascular bundle preservation during radical prostatectomy: long-term assessment of urinary and sexual function. Jpn. J. Clin. Oncol. 2005; 35: 6606.
  • 21
    Kaiho Y, Nakagawa H, Ikeda Y et al. Intraoperative electrophysiological confirmation of urinary continence after radical prostatectomy. J. Urol. 2005; 173: 113942.
  • 22
    Hu JC, Elkin EP, Pasta DJ et al. Predicting quality of life after radical prostatectomy: Results from CaPSURE. J. Urol. 2004; 171: 7037.
  • 23
    Stanford JL, Feng Z, Hamilton AS et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 2000; 283: 35460.
  • 24
    Namiki S, Ishidoya S, Saito S et al. Natural history of voiding function after radical retropubic prostatectomy. Urology 2006; 68: 14247.
  • 25
    Slova D, Lepor H. The short-term and long-term effects of radical prostatectomy on lower urinary tract symptoms. J. Urol. 2007; 178: 2397400.
  • 26
    Litwin MS, Pasta DJ, Yu J et al. Urinary function and bother after radical prostatectomy or radiation for prostate cancer: A longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J. Urol. 2000; 164: 19737.
  • 27
    Namiki S, Kwan L, Kagawa-Singer M et al. Sexual function reported by Japanese and American men. J. Urol. 2008; 179: 2459.
  • 28
    Namiki S, Kwan L, Kagawa-Singer M et al. Sexual function following radical prostatectomy: A prospective longitudinal study of cultural differences between Japanese and American men. Prostate Cancer Prostatic Dis. 2008; 11: 298302.
  • 29
    Hisasue S, Kumamoto Y, Sato Y et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: A Japanese female cohort study. Urology 2005; 65: 1438.
  • 30
    Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J. Urol. 2000; 164: 192934.
  • 31
    Kondu SD, Roehl KA, Eggener SE, Antenor JAV, Han M, Catalona WJ. Potency, continence and complications in 3477 consecutive radical retropubic prostatectomies. J. Urol. 2004; 172: 222731.